Burn News and Research

RSS

Infinity provides guidance on anticipated pipeline and business goals for 2011

Infinity Pharmaceuticals, Inc. today provided guidance on its anticipated pipeline and business goals for 2011. Infinity begins the year with a broad pipeline of four drug candidates in clinical development and a fifth expected to enter the clinic during the year. The company also enters 2011 with approximately $345 million in committed capital.

7 Jan 2011

Using TMV to control temperature of children's bath water can reduce risk of scalding: Researchers

Using a thermostatic mixer valve to control the maximum temperature of children's bath water can significantly reduce the temperature of hot bath water and should reduce the risk of scalding, according to researchers at The University of Nottingham.

6 Jan 2011

Sugared-sweetened beverages eliminated from Nationwide Children's Hospital campus

According to the American Academy of Pediatrics, sweetened drinks are the primary source of added sugar in the daily diet of children. Each 12-ounce serving of a carbonated, sweetened soft drink contains the equivalent of 10 teaspoons of sugar and 150 calories. A child who consumes one can of regular soda needs to walk 45 minutes just to burn it off.

5 Jan 2011

Betulin in birch bark appears to provide metabolic benefits

An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.

5 Jan 2011

Personality characteristics impact psychological recovery after breast cancer treatment

Certain personality traits are linked to higher quality-of-life scores in breast cancer patients who undergo breast reconstruction after mastectomy, reports a study in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

4 Jan 2011

Late-preterm infants often treated as developmentally mature, when not

In the last 15 years the U.S has seen a sharp increase in the number of babies born as late-preterm infants, between 34 and 37 weeks' gestation. This is approximately 400,000 children each year, comprising over 70 percent of all preterm births. Often, late-preterm infants are treated the same as full-term infants since they are commonly a similar size and weight. Growing research is showing that this can be detrimental to a late-preterm infant's health and frequently results in readmission to the hospital within the first month of life.

4 Jan 2011

Aging linked to changes in eye sockets, jaw bones

What makes us look older? Wrinkles and sagging result not just from changes in the skin, but also from aging-related changes in the underlying facial bones, according to a report in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

4 Jan 2011

Race to have the first baby of the new year

"The race to have the first baby is something all hospitals share enthusiasm for, especially in large cities like Chicago, and, unfortunately, not all hospitals play fair," said Karen Deighan, MD, OB/GYN, director of OB/GYN at Gottlieb Memorial Hospital, part of Loyola University Health System.

30 Dec 2010

Children more likely to suffer from appendicitis in areas with few pediatricians

Children who live in areas with fewer pediatricians are more likely to suffer life-threatening ruptures of the appendix than those in areas with more pediatricians, even when accounting for other factors such as the number of hospitals, imaging technology, insurance coverage and the number of surgeons in an area, according to a study from the Johns Hopkins Children's Center.

30 Dec 2010

CFTR protein regulates inflammation and cell death in emphysema, chronic lung diseases

A team of Johns Hopkins Children's Center researchers has discovered that a protein involved in cystic fibrosis also regulates inflammation and cell death in emphysema and may be responsible for other chronic lung diseases.

29 Dec 2010

Key to long-term weight-loss success is finding unique individual level of carbohydrate tolerance

Recent media coverage suggests that the reported wedding diet of Carole Middleton, mother of future British princess Kate Middleton, is something brand new. Yet the Dukan Diet is just another variation of the Atkins Diet™, but with some nutritional recommendations that simply don't make sense or are guaranteed to fail.

23 Dec 2010

BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients

BioCryst Pharmaceuticals, Inc. announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone.

22 Dec 2010

Wishard expands partnership with SIS to improve perioperative services

Wishard Health Services has expanded its partnership with Surgical Information Systems by adding anesthesia, business intelligence and patient tracking capabilities to its existing SIS perioperative system.

21 Dec 2010

Researchers discover new way to prevent spread of cancer

Scientists now know that some cancer cells spread, or metastasize, throughout the body the old-fashioned way -- by using their feet. But researchers at Duke Cancer Institute have discovered a way to short-circuit their travels by preventing the development of these feet, called invadopodia. This discovery is even more important because preventing the development of these "feet" also eliminates the action of proteins present in the feet that burn through intact tissue and let cancer cells enter new cells.

17 Dec 2010

AHA recognizes UC Irvine Medical Center's commitment to high-quality cardiac care

The American Heart Association has recognized UC Irvine Healthcare's commitment to the highest standards of care for heart failure patients.

17 Dec 2010

Access announces $6.0 million registered direct offering

ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, has entered into definitive agreements with existing and new accredited investors to sell, in a registered direct offering, an aggregate of approximately 2.3 million shares of its common stock at a price of $2.55 per share for aggregate gross proceeds of $6.0 million.

10 Dec 2010

Using buprenorphine to treat opioid-dependent pregnant women may result in healthier babies

Using buprenorphine instead of methadone — the current standard of care — to treat opioid-dependent pregnant women may result in healthier babies, suggests new findings from an international team led by Johns Hopkins researchers and published in the Dec. 9 issue of the New England Journal of Medicine.

10 Dec 2010

FDA grants approval to manufacture Collagenase SANTYL Ointment at DPT Laboratories' facility

Healthpoint today announced that the U.S. Food and Drug Administration has granted approval to manufacture commercial supplies of Collagenase SANTYL Ointment, a biologic enzymatic debriding agent, at DPT Laboratories' Center of Excellence for Sterile & Specialty Products facility in Lakewood, New Jersey.

10 Dec 2010

DPT granted FDA approval to manufacture Collagenase SANTYL Ointment for wound care

DPT Laboratories, Ltd., a pharmaceutical contract development and manufacturing organization, announced today that it received FDA approval to manufacture commercial supplies of a leading sterile ointment for wound care at its Center of Excellence for Sterile & Specialty Products in Lakewood, N.J. Beginning this month, Healthpoint will ship commercial lots of Collagenase SANTYL® Ointment produced at DPT's Lakewood facility to its North American customers.

9 Dec 2010

Researchers synthesize wound-healing peptides

Newly-created bioactive peptides promote wound healing through the growth of new blood vessels and epithelial tissue, such as skin. These wound-healing peptides, synthesized by researchers at the Tufts Center for Innovations in Wound Healing Research, increased angiogenesis in vitro by 200 percent.

8 Dec 2010

Burn News and Research

Infinity provides guidance on anticipated pipeline and business goals for 2011

Using TMV to control temperature of children's bath water can reduce risk of scalding: Researchers

Sugared-sweetened beverages eliminated from Nationwide Children's Hospital campus

Betulin in birch bark appears to provide metabolic benefits

Personality characteristics impact psychological recovery after breast cancer treatment

Late-preterm infants often treated as developmentally mature, when not

Aging linked to changes in eye sockets, jaw bones

Race to have the first baby of the new year

Children more likely to suffer from appendicitis in areas with few pediatricians

CFTR protein regulates inflammation and cell death in emphysema, chronic lung diseases

Key to long-term weight-loss success is finding unique individual level of carbohydrate tolerance

BioCryst commences BCX4208/allopurinol combination Phase 2b study in gout patients

Wishard expands partnership with SIS to improve perioperative services

Researchers discover new way to prevent spread of cancer

AHA recognizes UC Irvine Medical Center's commitment to high-quality cardiac care

Access announces $6.0 million registered direct offering

Using buprenorphine to treat opioid-dependent pregnant women may result in healthier babies

FDA grants approval to manufacture Collagenase SANTYL Ointment at DPT Laboratories' facility

DPT granted FDA approval to manufacture Collagenase SANTYL Ointment for wound care

Researchers synthesize wound-healing peptides

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News